Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: J Clin Gastroenterol. 2017 Feb;51(2):e11–e16. doi: 10.1097/MCG.0000000000000591

Table 1.

Baseline demographic data for the study subjects.

Enrolled in Study (N=19) Completed Study (N=15)

Median age at enrollment, years ±SD 45±11 49±11

Male Sex, % 74% 73%

Median BMI, ±SD 25±5 24±5

Race
    Caucasian 14 11
    African American 3 2
    Other 2 2

PSC Classification
    Large-duct 12 9
    Small-duct 7 6

Inflammatory Bowel Disease 15 12
    Ulcerative Colitis 13 11
    Crohn's Disease 2 1

Median Mayo PSC Risk Score* ±SD −0.03±0.71 −0.05±0.59

Median daily dose of UDCA, mg/kg ±SD 16±6 16±7
*

Mayo PSC Risk Score Formula: R = 0.03 (age [y]) + 0.54 loge (bilirubin [mg/dL]) + 0.54 loge (aspartate aminotransferase [U/L]) + 1.24 (variceal bleeding [0/1]) - 0.84 (albumin [g/dL]).